SWOG clinical trial number
SWOG-9347 (INT-0142) (E3193)
Phase III Comparison of Tamoxifen versus Tamoxifen with Ovarian Ablation in Premenopausal Women with Axillary Node-Negative Receptor-Positive Breast Cancer < 3 cm, Intergroup
Closed
Phase
Published
Abbreviated Title
Phase III Comparison of Tamoxifen versus Tamoxifen with Ovarian Ablation in Premenopausal Women with Axillary Node-Negative Receptor-Positive Breast Cancer < 3 cm, Intergroup
Activated
10/15/1994
Closed
11/06/1997
Publication Information Expand/Collapse
2003
Phase III comparison of tamoxifen versus tamoxifen with ovarian ablation in premenopausal women with axillary node-negative receptor-positive breast cancer < 3 cm